학술논문
RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144–152
Document Type
Correspondence
Author
Source
In European Journal of Cancer May 2017 77:21-23
Subject
Language
ISSN
0959-8049